Loading clinical trials...
Loading clinical trials...
Letrozole is an aromatase inhibitor that is approved in the first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breas...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Rutgers, The State University of New Jersey
Collaborators
NCT05468034 · Breast Cancer, Indolent Metastatic Breast Cancer
NCT07347600 · Locally Advanced Breast Cancer, Metastatic Breast Cancer
NCT07085767 · Breast Cancer, Locally Advanced Breast Cancer, and more
NCT05660083 · HER2-negative Breast Cancer, Metastatic Breast Cancer, and more
NCT07354022 · Locally Advanced or Metastatic Breast Cancer
Georgetown University Hospital
Washington D.C., District of Columbia
Emory University
Atlanta, Georgia
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions